Aimei Health Technology Co., Ltd.
Business
Aimei Health Technology Co., Ltd. is a blank-check company (SPAC) incorporated in the Cayman Islands to identify and acquire small-cap businesses in biopharmaceutical, medical technology, medical devices, and diagnostics. The company has entered into a definitive business combination agreement with United Hydrogen Group Inc., a hydrogen technology company with PRC-based operations, pending regulatory approvals including from China's CSRC. The company targets healthcare innovation across North America, Europe, and Asia-Pacific regions.
Summary from 10-K filed 2026-05-04
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 |
|---|---|---|---|
| General, administrative and operational costs | −835,759 | −1 | |
| Loss from operations | −835,759 | −1 | |
| Interest earned on cash held in trust | 2 | 4 | |
| Total other income, net | 2 | 4 | |
| NET INCOME | 1 | 3 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2023 2023-08-31 | FY 2023 2023-04-30 |
|---|---|---|---|---|---|---|
| Cash | 2,929 | 28,208 | 580,717 | 25,000 | — | |
| Prepaid expenses | — | 2,176 | — | — | — | |
| Total current assets | 2,929 | 30,384 | 580,717 | — | — | |
| Cash held in Trust Account | 12 | 74 | 70 | — | — | |
| TOTAL ASSETS | 12 | 74 | 70 | — | — | |
| Accrued expenses | 447,997 | 299,514 | 24,841 | — | — | |
| Extension loans related party | 2 | 227,700 | — | — | — | |
| Due to a related company | 899,601 | 289,780 | — | — | — | |
| Total current liabilities | 3 | 816,994 | 24,841 | — | — | |
| Deferred underwriter fee payable | 690,000 | 690,000 | 690,000 | — | — | |
| TOTAL LIABILITIES | 4 | 2 | 714,841 | — | — | |
| Commitments and contingencies (Note 7) | — | — | — | — | — | |
| Ordinary shares, subject to possible redemption. 1,040,332 and 6,900,000 shares issued and outstanding at redemption value of $11.63 and $10.69 as of December 31, 2025 and 2024, respectively | 12 | 74 | 70 | — | — | |
| Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 2,126,000 and 2,126,000 shares issued and outstanding as of December 31, 2025 and 2024, respectively (excluding 1,040,332 and 6,900,000 shares subject to possible redemption, respectively) | 213 | 213 | 213 | — | — | |
| Accumulated deficit | −4 | −1 | −134,337 | — | — | |
| Total shareholders deficit | −4 | −1 | −134,124 | — | — | |
| TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS DEFICIT | 12 | 74 | 70 | — | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 |
|---|---|---|---|
| Interest earned on cash held in trust | −2 | −4 | |
| Prepaid expenses | 2,176 | −2,176 | |
| Due to a related company | 120,000 | 120,000 | |
| Accrued expenses | 148,483 | 274,673 | |
| Net cash used in operating activities | −565,100 | −672,289 | |
| Cash withdrawn from Trust Account in connection with redemption | 65 | — | |
| Extension payments deposited in Trust Account | −2 | −277,700 | |
| Net cash provided by (used in) investing activities | 64 | −277,700 | |
| Proceeds from extension promissory note related party | 2 | 277,700 | |
| Advance from related party | 539,821 | 119,780 | |
| Redemption of ordinary shares | −65 | — | |
| Net cash provided by (used in) financing activities | −63 | 397,480 | |
| NET CHANGE IN CASH | −25,279 | −552,509 | |
| Remeasurement of ordinary shares subject to possible redemption | 2 | 4 | |
| Extension funds attributable to ordinary shares subject to redemption | 2 | 277,700 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Aimei Health Technology Co., Ltd.'s CIK number?
Aimei Health Technology Co., Ltd.'s SEC CIK number is 0001979005 (1979005). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Aimei Health Technology Co., Ltd.'s SEC filings?
All of Aimei Health Technology Co., Ltd.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.